AnaptysBio, Inc. (ANAB)

AnaptysBio Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	941	569	881	956	588	441
Market Cap Growth	-0.83%	-35.39%	-7.83%	62.57%	33.35%	-74.16%
Enterprise Value	583	196	459	429	195	68
PE Ratio	-	-3.48	-6.84	-16.54	-29.50	-4.53
PS Ratio	40.09	33.18	85.65	15.13	7.84	55.12
PB Ratio	19.27	6.46	3.36	2.68	1.48	1.09
P/FCF Ratio	-4.49	-4.68	-11.91	-20.22	-39.93	-6.27
P/OCF Ratio	-4.52	-4.71	-11.97	-20.82	-41.53	-6.34
EV/Sales Ratio	25.41	11.43	44.65	6.79	2.60	8.50
EV/EBITDA Ratio	-1.65	-1.22	-3.63	-7.70	-10.63	-0.72
EV/EBIT Ratio	-1.63	-1.20	-3.57	-7.42	-9.77	-0.71
EV/FCF Ratio	-1.98	-1.61	-6.21	-9.07	-13.22	-0.97
Debt / Equity Ratio	0.36	0.20	0.07	0.06	0.00	0.00
Debt / EBITDA Ratio	-0.11	-0.11	-0.15	-0.38	-0.02	-0.01
Debt / FCF Ratio	-0.13	-0.15	-0.26	-0.44	-0.02	-0.02
Quick Ratio	11.20	10.62	16.99	34.10	19.86	12.67
Current Ratio	11.53	10.87	17.17	34.40	20.01	12.79
Asset Turnover	0.05	0.03	0.02	0.13	0.18	0.02
Interest Coverage	-	-	-	-	-	-92.65
Return on Equity (ROE)	-161.40%	-119.40%	-43.80%	-15.30%	-5.20%	-22.30%
Return on Assets (ROA)	-35.10%	-32.60%	-20.90%	-12.20%	-4.90%	-20.90%
Return on Capital (ROIC)	-248.92%	-155.23%	-40.90%	-15.05%	-6.01%	-26.44%
Earnings Yield	-17.74%	-28.74%	-14.61%	-6.05%	-3.39%	-22.08%
FCF Yield	-14.57%	-21.36%	-8.39%	-4.95%	-2.50%	-15.95%
Buyback Yield / Dilution	4.12%	4.41%	-2.68%	-0.47%	-0.90%	-9.67%
Total Shareholder Return	4.12%	4.41%	-2.68%	-0.47%	-0.90%	-9.67%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).